177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial

Michael J. Morris, Daniel Castellano, Ken Herrmann, +20

The Lancet

UrologyOncologyGenitourinary Cancer177Lu-psma-617 VersusMedicine +6

Overall survival and response pattern of castration-resistant metastatic prostate cancer to multiple cycles of radioligand therapy using [177Lu]Lu-PSMA-617

Hojjat Ahmadzadehfar, Simone Wegen, Anna Yordanova, +7

European Journal of Nuclear Medicine and Molecular Imaging

UrologyRadiologyRadioligand TherapyGenitourinary CancerMedicine +5

Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma

Ziad Bakouny, David A. Braun, Sachet A. Shukla, +50

Nature Communications

Tumor fraction in cell-free DNA as a biomarker in prostate cancer

Atish D. Choudhury, Lillian Werner, Edoardo Francini, +19

JCI Insight

Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid Features

Bradley A. McGregor, Rana R. McKay, David A. Braun, +17

Journal of Clinical Oncology

The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non–Clear Cell Renal Cell Carcinoma

Rana R. McKay, Dominick Bossé, Wanling Xie, +23

Cancer Immunology Research

Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade

Chien-Chun Steven Pai, John Huang, Xiaoqing Lu, +24

Immunity

Tumor-specific T CellsTumor ImmunologyCancer ImmunosurveillanceClonal DeletionImmunology +8

Results from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in muscle invasive bladder cancer (MIBC) undergoing cystectomy.

Shilpa Gupta, Guru Sonpavde, Christopher Weight, +17

Journal of Clinical Oncology

Radical CystectomySurgical OncologyUrologyPd-l1 ExpressionGenitourinary Cancer +10

Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic Prostate Cancer

Rahul Aggarwal, Xiao X. Wei, Won Bae Kim, +6

European Urology Oncology

Metastatic Prostate CancerUrologyEngineeringGenitourinary CancerHeterogeneous Flare +6

Optimized Management of Nivolumab and Ipilimumab in Advanced Renal Cell Carcinoma: A Response-Based Phase II Study (OMNIVORE)

Rana R. McKay, Bradley A. McGregor, Wanling Xie, +10

Journal of Clinical Oncology